Last Posted: Aug 02, 2018
- Pharmacogenomics and the Future of Pharmacy
J Sederstrom, Drug Topics, July 2018 - The Road to There`
C Herrera, American Heart Association Blog, July 16, 2018 - DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies.
Story Jovanova Olivera et al. JAMA psychiatry 2018 Jul - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Information for Healthcare Providers - A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).
Grieco Joseph C et al. The patient 2018 Jul - Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.
Zastrozhin Mikhail Sergeevich et al. Pharmacogenomics and personalized medicine 2018 11113-119 - New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies.
Hampton Tracy et al. JAMA 2018 Jul 320(1) 20-21 - New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies
T Hampton, JAMA, July 3, 2018 - People who have a family history of thyroid disease are more likely to have hyperthyroidism.
NIDDK, 2018 - Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
Fabbri Chiara et al. Neuroscience letters 2018 Jun
.png)
No hay comentarios:
Publicar un comentario